Health in Laos 1,068 indicators covering health for Laos. IndicatorLatest Year10-yr change Rank Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 74.0% 2025 down 14.9% 179th Implementation of tools to monitor economic and environmental tourism 2 2019 unchanged 62nd New HIV infections 0.17 2025 down 10.5% 56th Stunting prevalence among children under 5 years of age (%) 29.9% 2024 down 21.9% 27th Stunting numbers among children under 5 years of age (millions) 236.3 2024 down 20.4% 67th Overweight numbers among children under 5 years of age (thousands) 29.4 2024 up 60.7% 102nd Overweight prevalence among children under 5 years of age (%) 3.7% 2024 up 54.2% 124th People using safely managed drinking water services, urban 50.9% 2024 up 160.1% 78th Mean HDL cholesterol, age-standardized 1 2018 unchanged 155th Mean total cholesterol, crude 4.3 2018 unchanged 122nd Mean Non-HDL cholesterol, age-standardized 3.3 2018 up 3.1% 93rd Mean HDL cholesterol, crude 1 2018 unchanged 154th Mean Non-HDL cholesterol, crude 3.3 2018 up 6.5% 97th Mean total cholesterol, age-standardized 4.4 2018 unchanged 112th Prevalence of anemia among children 41.4% 2019 down 4.6% 61st Births attended by skilled health staff 64.4% 2017 up 240.7% 152nd Births attended by health staff sdgs 64.4 2017 up 240.7% 152nd Number of deaths among children ages 10 to 14 years 640 2021 down 33.3% 62nd Adolescent mortality rate 4.26 2021 down 33.2% 34th Adults (ages 15+) living with HIV 20,000 2024 up 66.7% 80th Prevalence of current tobacco use 25.4% 2024 down 22.3% 47th Prevalence of current tobacco use, females 8.3% 2024 down 40.3% 76th Prevalence of current tobacco use, males 42.5% 2024 down 17.3% 30th BCG immunization coverage among 1-year-olds (%) 87.0% 2025 down 1.1% 113th Physicians per 1000 people 0.331 2022 up 3.1% 149th Physicians 0.331 per 1,000 people 2022 up 3.1% 149th Share of the population infected with hiv 0.418 2024 up 34.8% 74th Global vaccination coverage 67 2024 down 19.3% 169th Proportion of population with primary reliance on clean fuels and 3.0% 2024 up 200.0% 165th Number of incident tuberculosis cases 9,900 2024 down 23.8% 70th Incidence of tuberculosis 127 2024 down 32.8% 54th Number of incident tuberculosis cases 410 2024 down 57.7% 74th Number of deaths due to tuberculosis, excluding HIV 640 2024 down 82.2% 74th Deaths due to tuberculosis among HIV-negative people 8.2 2024 down 84.8% 66th Tuberculosis deaths by hiv status 64 2024 down 76.3% 80th Tuberculosis case fatality rate 7 2024 down 78.8% 130th Life satisfaction vs child mortality 5.51 2025 up 13.1% 92nd Incidence of tuberculosis sdgs 127 2024 down 32.8% 55th Tuberculosis deaths region 700 2024 down 82.1% 80th Tuberculosis death rate 9 2024 down 84.5% 70th Tuberculosis deaths who 700 2024 down 82.1% 80th People using safely managed sanitation services, rural 72.7% 2024 up 49.4% 22nd Tuberculosis patients with hiv share 4.2 2024 down 44.7% 89th Life expectancy prados de la escosura 68.5 2020 up 7.1% 111th Prevalence of hiv percentage of males and females ages 15 24 infected 0.2 2024 unchanged 50th Adults (ages 15+) and children (ages 0-14) newly infected with HIV 1,300 2024 up 8.3% 69th Tuberculosis - new and relapse cases 8,965 2024 up 103.9% 63rd Tuberculosis treatment coverage 91 2024 up 160.0% 30th AIDS estimated deaths 500 UNAIDS estimates 2024 unchanged 64th Mean BMI (kg/m²) 22.9 2016 up 5.5% 163rd Rubella - number of reported cases 23 2025 down 48.9% 40th Treatment success rate: new TB cases 90 2023 up 3.4% 43rd Yellow fever - number of reported cases 0 2021 — 26th Current health expenditure per capita, PPP 123.25 current international $ 2023 down 1.6% 178th Out-of-pocket expenditure per capita, PPP 55.27 current international $ 2023 down 9.4% 160th Domestic general government health expenditure 0.5% 2023 down 25.9% 186th Domestic private health expenditure per capita, PPP 55.27 current international $ 2023 down 14.0% 166th Domestic general government health expenditure per capita 10.91 current US$ 2023 down 15.5% 168th Share of out of pocket expenditure on healthcare 44.84 2023 down 7.9% 45th Tuberculosis treatment success rate in new and relapsed cases 90 2023 up 3.4% 49th ← Previous Page 9 of 18 Next →